Found: 9
Select item for more details and to access through your institution.
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.
- Published in:
- Diabetologia, 2016, v. 59, n. 6, p. 1153, doi. 10.1007/s00125-016-3917-4
- By:
- Publication type:
- Article
Reply to Andréasson : Multiple Manifestations of Systemic Sclerosis Affect Walk Distance.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 2, p. 307, doi. 10.1002/acr.24785
- By:
- Publication type:
- Article
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 8, p. 3285, doi. 10.1172/JCI81722
- By:
- Publication type:
- Article
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
- Published in:
- Rheumatology, 2022, v. 61, n. 10, p. 4155, doi. 10.1093/rheumatology/keac015
- By:
- Publication type:
- Article
Large‐Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 4, p. 660, doi. 10.1002/art.41570
- By:
- Publication type:
- Article
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long‐Term Normalization of Systemic Sclerosis Molecular Signatures.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 8, p. 1288, doi. 10.1002/art.42847
- By:
- Publication type:
- Article
2. Durable Efficacy of Alefacept in New-Onset Type 1 Diabetes: Evidence for Lasting Modulation of Effector and Regulatory T Cells (231-OR).
- Published in:
- Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 56, doi. 10.1007/s12467-015-0023-z
- By:
- Publication type:
- Article